When underlying biology threatens the randomization principle — initial gout flares of urate-lowering therapy

Interpreting the Results of Intention-to-Treat, Per-Protocol, and As-Treated Analyses of Clinical Trials

(2021) Valerie A. Smith et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Serum urate as a proposed surrogate outcome measure in gout trials: From the OMERACT working group

(2021) Melanie Birger Morillon et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

2020 American College of Rheumatology Guideline for the Management of Gout

(2020) John D. FitzGerald et al.   Arthritis & Rheumatology

The experience of a gout flare: a meta-synthesis of qualitative studies

(2020) Sarah Stewart et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine

(2020) Lindsey R. Baden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

(2020) Fernando P. Polack et al.   NEW ENGLAND JOURNAL OF MEDICINE

Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma

(2018) Keith M. Sullivan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum urate as surrogate endpoint for flares in people with gout: A systematic review and meta-regression analysis

(2018) Lisa Stamp et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Implication of nurse intervention on engagement with urate-lowering drugs: A qualitative study of participants in a RCT of nurse led care

(2018) Zahira P. Latif et al.   JOINT BONE SPINE

Efficacy and cost-effectiveness of nurse-led care involving education and engagement of patients and a treat-to-target urate-lowering strategy versus usual care for gout: a randomised controlled trial

(2018) Michael Doherty et al.   LANCET

Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN)

(2017) Nicola Dalbeth et al.   Nature Reviews Rheumatology

Per-Protocol Analyses of Pragmatic Trials

(2017) Miguel A. Hernán et al.   NEW ENGLAND JOURNAL OF MEDICINE

Editorial: Do Not Let Gout Apathy Lead to Gouty Arthropathy

(2017) John D. FitzGerald et al.   Arthritis & Rheumatology

To Treat or Not to Treat (to Target) in Gout

(2016) Tuhina Neogi et al.   ANNALS OF INTERNAL MEDICINE

The Long and Winding Road to Clinical Guidelines on the Diagnosis and Management of Gout

(2016) Robert M. McLean   ANNALS OF INTERNAL MEDICINE

Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians

(2016) Amir Qaseem et al.   ANNALS OF INTERNAL MEDICINE

Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study)

(2016) Thomas Bardin et al.   ANNALS OF THE RHEUMATIC DISEASES

2016 updated EULAR evidence-based recommendations for the management of gout

(2016) P Richette et al.   ANNALS OF THE RHEUMATIC DISEASES

Lesinurad Combined With Allopurinol: A Randomized, Double-Blind, Placebo-Controlled Study in Gout Patients With an Inadequate Response to Standard-of-Care Allopurinol (a US-Based Study)

(2016) Kenneth G. Saag et al.   Arthritis & Rheumatology

A Randomized, Controlled Trial of Total Knee Replacement

(2015) Søren T. Skou et al.   NEW ENGLAND JOURNAL OF MEDICINE

Why post-progression survival and post-relapse survival are not appropriate measures of efficacy in cancer randomized clinical trials

(2014) Xabier García-Albéniz et al.   INTERNATIONAL JOURNAL OF CANCER

Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis

(2014) Jacob M. van Laar et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Rilonacept for gout flare prevention during initiation of uric acid-lowering therapy: results from the PRESURGE-2 international, phase 3, randomized, placebo-controlled trial

(2013) Essack Mitha et al.   RHEUMATOLOGY

2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

(2012) Dinesh Khanna et al.   ARTHRITIS CARE & RESEARCH

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study

(2011) N. Schlesinger et al.   ANNALS OF THE RHEUMATIC DISEASES

Landmark Analysis at the 25-Year Landmark Point

(2011) Urania Dafni  

Effect of Prophylaxis on Gout Flares After the Initiation of Urate-Lowering Therapy: Analysis of Data From Three Phase III Trials

(2011) Robert L. Wortmann et al.   CLINICAL THERAPEUTICS

Pegloticase and Chronic Gout--Reply

(2011) J. S. Sundy et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

The practical management of gout

(2009) H. R. SCHUMACHER et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Outcome Domains for Studies of Acute and Chronic Gout

(2009) H. R. SCHUMACHER et al.   JOURNAL OF RHEUMATOLOGY

Treating to target: a strategy to cure gout

(2009) F. Perez-Ruiz   RHEUMATOLOGY

Determinants of the Clinical Outcomes of Gout During the First Year of Urate-Lowering Therapy

(2008) Michael A. Becker et al.   NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS